Literature DB >> 18716848

National evaluation of policies on individual financial conflicts of interest in Canadian academic health science centers.

Joel Lexchin1, Melanie Sekeres, Jennifer Gold, Lorraine E Ferris, Sunila R Kalkar, Wei Wu, Marleen Van Laethem, An-Wen Chan, David Moher, M James Maskalyk, Nathan Taback, Paula A Rochon.   

Abstract

BACKGROUND: Conflicts of interest (COI) in research are an important emerging topic of investigation and are frequently cited as a serious threat to the integrity of human participant research.
OBJECTIVE: To study financial conflicts of interest (FCOI) policies for individual investigators working in Canadian academic health centers.
DESIGN: Survey instrument containing 61 items related to FCOI.
SETTING: All Canadian academic health science centers (universities with faculties of medicine, faculties of medicine and teaching hospitals) were requested to provide their three primary FCOI policies. MEASUREMENTS: Number of all centers and teaching hospitals with policies addressing each of the 61 items related to FCOI. MAIN
RESULTS: Only one item was addressed by all 74 centers. Thirteen items were present in fewer than 25% of centers. Fewer than one-quarter of hospitals required researchers to disclose FCOI to research participants. The role of research ethics boards (REBs) in hospitals was marginal. LIMITATIONS: Asking centers to identify only three policies may not have inclusively identified all FCOI policies in use. Additionally, policies at other levels might apply. For instance, all institutions receiving federal grant money must comply with the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans.
CONCLUSIONS: Canadian centers within the same level (for instance, teaching hospitals) differ significantly in the areas that their policies address and these policies differ widely in their coverage. Presently, no single policy in any Canadian center informs researchers about the broad range of individual FCOI issues. Canadian investigators need to understand the environment surrounding FCOI, be able to access and follow the relevant policies and be confident that they can avoid entering into a FCOI.

Entities:  

Mesh:

Year:  2008        PMID: 18716848      PMCID: PMC2585679          DOI: 10.1007/s11606-008-0752-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  15 in total

1.  Controversy of the year. Biomedical ethics on the front burner.

Authors: 
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

2.  Policies on faculty conflicts of interest at US universities.

Authors:  M K Cho; R Shohara; A Schissel; D Rennie
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

3.  Early Toronto experience with new standards for industry-sponsored clinical research: a progress report.

Authors:  C David Naylor
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

4.  Relationship between conflicts of interest and research results.

Authors:  Lee S Friedman; Elihu D Richter
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

Review 5.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

6.  Financial conflict-of-interest policies in clinical research: issues for clinical investigators.

Authors:  Elizabeth A Boyd; Mildred K Cho; Lisa A Bero
Journal:  Acad Med       Date:  2003-08       Impact factor: 6.893

7.  Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ.

Authors:  Lise L Kjaergard; Bodil Als-Nielsen
Journal:  BMJ       Date:  2002-08-03

8.  Three journals raise doubts on validity of Canadian studies.

Authors:  Caroline White
Journal:  BMJ       Date:  2004-01-10

9.  Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets.

Authors:  Lorraine E Ferris; C David Naylor
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

10.  Comparison of conflict of interest policies and reported practices in academic medical centers in the United States.

Authors:  Michaela A Dinan; Kevin P Weinfurt; Joëlle Y Friedman; Jennifer S Allsbrook; Julie Gottlieb; Kevin A Schulman; Mark A Hall; Jatinder K Dhillon; Jeremy Sugarman
Journal:  Account Res       Date:  2006 Oct-Dec       Impact factor: 2.622

View more
  4 in total

1.  Correlation between financial relationships with commercial interests and research prominence at an oncology meeting.

Authors:  Beverly Moy; Angela R Bradbury; Paul R Helft; Brian L Egleston; Moktar Sheikh-Salah; Jeffrey Peppercorn
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

2.  Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.

Authors:  Joel Lexchin
Journal:  Sci Eng Ethics       Date:  2011-02-15       Impact factor: 3.525

3.  Research ethics committees in the regulation of clinical research: comparison of Finland to England, Canada, and the United States.

Authors:  Elina Hemminki
Journal:  Health Res Policy Syst       Date:  2016-01-19

4.  "We can't get along without each other": Qualitative interviews with physicians about device industry representatives, conflict of interest and patient safety.

Authors:  Anna R Gagliardi; Pascale Lehoux; Ariel Ducey; Anthony Easty; Sue Ross; Chaim Bell; Patricia Trbovich; David R Urbach
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.